Overview

Genomics Market Introduction

Global Genomics Market is estimated to value over USD 29 billion by 2027 end and record a CAGR of over 12.1% during the forecast period 2020 to 2027.

The augmentation of the genomic pool data owing to research and development activities has allowed biologists, patients and physicians to further understand the predisposition of genomes to specific diseases. Applications of this pool of data is predicted to be an integral factor in the transformation of the healthcare system with reference to more effective, reliable and accurate solutions for managing diseases.

The research and healthcare community are making efforts to effectively integrate genetic information into clinical systems. Multiple clinical centres, for instance, Stanford Health Care, have taken initiatives in using the accessible information of genes in order to design a regime of personalized treatment. This aids in bridging the gap between clinical treatment and diagnosis and translational research.

Rising number of investments done by the biotechnology companies, the funding agencies and the government to speed up the research activities in genomics is predicted to have major consequences on the global genomics market growth. International bodies like Welcome Trust and NIH are providing financial backing for genetic studies, which is expected to spur the genomic research scenario in developing as well as developed economies.

The most crucial factor predicted to affect the proliferation of this market is to what extent the healthcare community will use the accessible information of genomes for personalized medicine. Scientists are combining diagnostics with the data generated from sequencing, which is an effective technique in inflating the landscape of personalized treatment.

Generating a lot of data for genomic sequencing has resulted into substantial augmentation of functional genomics. The development of technologies providing high-throughput for protein as well as gene research studies has bolstered the segment growth. The genome industry is making progress from analysing proteomes and the entire genome sequence as well as individual genes within a short span of time shows the proliferation of this segment. Integration of solutions providing high-throughput in genomics that are functioning has offered the likeability of productive drugs with lesser harmful effects. Moreover, the usage of behavioural genetics hold immense global market potential for evaluating peculiarities of particular behaviour and competitive hypotheses with respect to modules.

With the decline in the cost of gene sequencing and improvement in the provision of genetic and informatics solutions are now comprehensively available in different sectors ranging from clinical settings to small labs. Important user segments include biotechnology and pharmaceutical companies, academic and government institutes, clinics and hospitals and other end users. Amidst all these segments, the biotechnology and pharmaceutical companies accounted the largest global genomics market share due to an increase in genetic research activities that focused at development of effective drugs with fewer side effects and improving the process of drug discovery.

The Asia Pacific region is predicted to exhibit rapid growth in the upcoming years. The infrastructural development in these nations has resulted into the risen insistence for biomarkers to be used for diagnosis. The global market is projected to proliferate due to an increase in the awareness and adoption of numerous genomic technologies in the developing nations such as India and China for prognosis, detection and treatment of multiple genetic disorders for instance, cancer, diabetes and others.

Market Segmentation:

By Product and Service

• Consumables
• Systems & Software
• Services

By Technology

• PCR
• Sequencing
• Microarray
• Nuclei Acid Extraction and Purification
• Other Technologies

By Application

• Diagnostics
• Drug Discovery
• Precision Medicine
• Agriculture & Animal Research
• Other Applications

By End User

• Research Centres and Academic & Government Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other End Users

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

 

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

 

Objectives of the Study:

• To provide with an exhaustive analysis on the global genomics market by product and service, by technology, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific Latin America and Middle East & Africa
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents

1 Introduction 

    1.1 Objectives of the Study 

    1.2 Market Definition 

    1.3 Market Scope 

           1.3.1 Markets Covered

           1.3.2 Years Considered for the Study

    1.4 Currency 

    1.5 Limitations 

    1.6 Stakeholders

 

2 Research Methodology 

    2.1 Research Data 

           2.1.1 Secondary Data

                    2.1.1.1 Key Data From Secondary Sources

           2.1.2 Primary Data

                    2.1.2.1 Key Data From Primary Sources

                    2.1.2.2 Key Industry Insights

    2.2 Market Size Estimation 

           2.2.1 Market Data Validation and Triangulation

    2.3 Assumptions for the Study

 

3 Executive Summary 

 

4 Premium Insights 

    4.1 Genomics: Market Overview 

    4.2 North America: Market, By Technology, 2019 

    4.3 Asia Pacific: Market, By Product & Service, 2019 

    4.4 Geographical Snapshot of the Market

 

5 Market Overview 

    5.1 Introduction 

    5.2 Market Dynamics 

           5.2.1 Drivers

                    5.2.1.1 Rising Government Funding and Growth in the Number of Genomics Projects

                    5.2.1.2 Decreasing Sequencing Costs

                    5.2.1.3 Growing Application Areas of Genomics

                    5.2.1.4 Entry of New Players and Start-Ups in the Market

           5.2.2 Restraints

                    5.2.2.1 High Cost of Genomic Equipment

           5.2.3 Opportunities

                    5.2.3.1 Use of Genomics in Specialized/Personalized Medicine

           5.2.4 Challenges

                    5.2.4.1 Dearth of Trained Professionals

                    5.2.4.2 Secure Storage of Large Volumes of Sequenced Data

 

6 By Product and Service 

    6.1 Introduction 

    6.2 Consumables 

           6.2.1 Consumables Forms the Largest Segment of the Market

    6.3 Systems & Software 

           6.3.1 With Genome Sequencing Available at Substantially Lower Rates, the Demand for Systems & Software is Expected to Increase

    6.4 Services 

           6.4.1 The Services Segment is Expected to Grow at the Highest CAGR During the Forecast Period

 

7  By Technology 

    7.1 Introduction 

    7.2 PCR 

           7.2.1 PCR Allows Researchers to Produce Millions of Copies of A Specific Dna Sequence Within Hours

    7.3 Sequencing 

           7.3.1 Increasing Applications of Sequencing in Animal Breeding, Agriculture, and Human Genomics to Drive Market Growth

    7.4 Microarray 

           7.4.1 Microarray Technologies are Widely Used in the Field of Genomics Due to Their Low Cost

    7.5 Nucleic Acid Extraction and Purification 

           7.5.1 Advances in Nucleic Acid Extraction and Purification Technologies are Expected to Support the Growth of This Market

    7.6 Other Technologies

 

8 By Application 

    8.1 Introduction 

    8.2 Diagnostics 

           8.2.1 Diagnostics Forms the Largest and Fastest-Growing Application Segment of the Genomics Market

    8.3 Drug Discovery and Development 

           8.3.1 Growing Application of Genomics in the Area of Drug Discovery and Development to Propel Market Growth

    8.4 Precision Medicine 

           8.4.1 Precision Medicine Focuses on Identifying the Most Effective Medical Treatments for Patients Based on Their Genetic, Environmental, and Lifestyle Factors

    8.5 Agriculture & Animal Research 

           8.5.1 Genomics Helps in Improving the Productivity of Crops and Livestock

    8.6 Other Applications

 

9  By End User 

    9.1 Introduction 

    9.2 Research Centers and Academic & Government Institutes 

           9.2.1 Increase in Research Intensity to Drive the Usage of Genomics Systems Among Academic & Government Institutes

    9.3 Hospitals & Clinics 

           9.3.1 Increasing Demand for Pharmacogenomics to Drive the Acceptance of Ngs in Hospitals

    9.4 Pharmaceutical & Biotechnology Companies 

           9.4.1 Growing Importance of Biomarkers to Drive the Use of Genomic Systems and Services Among Pharma & Biotech Companies

    9.5 Other End Users

 

10 By Region 

     10.1 Introduction 

     10.2 North America 

             10.2.1 US

                        10.2.1.1 US Dominates the North American Genomics Market Due to the Increasing Research Funding and Government Initiatives for Promoting Precision Medicine and the Use of Gm Crops

             10.2.2 Canada

                        10.2.2.1 Increasing Research in the Field of Genomics to Drive Market Growth

     10.3 Europe 

             10.3.1 UK

                        10.3.1.1 UK to Register the Highest CAGR in the European Genomics Market During the Forecast Period

             10.3.2 Germany

                        10.3.2.1 Availability of Funding for Life Sciences Research to Boost Market Growth in Germany

             10.3.3 France

                        10.3.3.1 Increasing Government Investments in Genomics to Boost the Growth of the French Genomics Market

             10.3.4 RoE

     10.4 Asia Pacific 

             10.4.1 China

                        10.4.1.1 China is Expected to Command the Largest Share of the Asia Pacific Market

             10.4.2 India

                        10.4.2.1 Emergence of Local Players is Expected to Aid the Growth of the Market in India

             10.4.3 Japan

                        10.4.3.1 Increasing Government Focus on Cancer Research in Japan to Increase Demand for Genomics Products

             10.4.4 Rest of Asia Pacific

     10.5 Rest of the World 

             10.5.1 Middle East and Africa

                        10.5.1.1 Increasing Adoption of Genetic Testing in the Middle East and Rising Hiv & Cancer Incidence in Africa are Driving Market Growth

             10.5.2 Latin America

                        10.5.2.1 Government Funding and Partnerships to Boost the Adoption of Genomics Products and Services in Latin America

 

11 Competitive Landscape (Page No. - 126)

     11.1 Overview 

             11.1.1 Thermo Fisher Scientific

             11.1.2 Illumina

             11.1.3 Qiagen

             11.1.4 Others

     11.2 Competitive Scenario 

             11.2.1 Product Launches and Approvals

             11.2.2 Expansions

             11.2.3 Agreements and Collaborations

             11.2.4 Acquisitions

     11.3 Competitive Leadership Mapping (Overall Market) (2019) 

             11.3.1 Visionary Leaders

             11.3.2 Innovators

             11.3.3 Dynamic Differentiators

             11.3.4 Emerging Companies

     11.4 Competitive Benchmarking 

             11.4.1 Analysis of the Product Portfolio of Major Players in the  Market (25 Companies)

             11.4.2 Business Strategies Adopted By Major Players in the Market (25 Companies)

     11.5 Competitive Leadership Mapping (Start-Up) (2019) 

             11.5.1 Progressive Companies

             11.5.2 Starting Blocks

             11.5.3 Dynamic Companies

             11.5.4 Responsive Companies

12 Company Profiles 

     12.1 Illumina, Inc. 

     12.2 Thermo Fisher Scientific 

     12.3 Qiagen 

     12.4 Eurofins Scientific 

     12.5 Agilent Technologies 

     12.6 Oxford Nanopore Technologies 

     12.7 F. Hoffmann-La Roche 

     12.8 Bio-Rad Laboratories 

     12.9 BGI 

     12.10 Danaher Corporation 

     12.11 Ge Healthcare 

     12.12 Eppendorf

 

Chapter 12 Research Finding and Conclusion 

 

Chapter 13  Research Methodology 

Chapter 14  Research Data Source

 

Tables

Figures